• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    NRX Pharmaceuticals, Inc. - Common Stock (NQ:NRXP)

    1.855 +0.015 (+0.82%)
    Streaming Delayed Price Updated: 2:01 PM EST, Feb 23, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 285,545
    Open 1.840
    Bid (Size) 1.850 (3,000)
    Ask (Size) 1.860 (1,400)
    Prev. Close 1.840
    Today's Range 1.800 - 1.880
    52wk Range 1.580 - 3.840
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    FDA Meeting Indicates Path to New Drug Application with Real World Data and Broader Indication of NRX-100 (Ketamine) for Suicidal Depression: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
    Via Get News
    BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Completes FDA Type C Meeting for NRX-100 NDA Pathway
    Via Investor Brand Network

    Performance

    YTD
    -29.2%
    -29.2%
    1 Month
    -14.5%
    -14.5%
    3 Month
    -17.2%
    -17.2%
    6 Month
    -31.0%
    -31.0%
    1 Year
    -22.1%
    -22.1%

    More News

    Read More
    News headline image
    NRx Pharmaceuticals (Nasdaq:NRXP) Announces Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    NRx Pharmaceuticals (Nasdaq:NRXP) Announces 2025 Annual Meeting Date and Record Date
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    Why Did NRXP Stock Surge 21% Pre-Market Today? ↗
    Via Stocktwits
    News headline image
    Milestone Patient Data Eclipsing 70,000 on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
    Via Get News
    PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Licenses Real-World Evidence From 70,000 Patients to Support FDA Accelerated Approval of NRX-100
    Via Investor Brand Network
    News headline image
    NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Partners With neurocare Group AG To Build Nationwide Neuroplastic Care Network
    Via Investor Brand Network
    News headline image
    NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Eliminates Balance Sheet Debt Through Anson Equity Conversion
    Via Investor Brand Network
    News headline image
    NRx Pharmaceuticals (Nasdaq:NRXP) announces elimination of all balance sheet debt following equity conversion
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    More Than 1 Million Suicidal Depression Cases Per Year May Be Treated by 2030 via New Indication for Augmentation of Transcranial Magnetic Stimulation: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
    Via Get News
    BioMedNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Amends IND to Advance NRX-101 With TMS for Depression Treatment
    Via Investor Brand Network
    News headline image
    NRx Pharmaceuticals to discuss new NRX-101 pipeline indication for augmentation of Transcranial Magnetic Stimulation
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    FDA Submission for Abbreviated New Drug Application; $750 Million Market for Suicidal Depression Market Awaits Preservative-Free IV Ketamine: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
    Via Get News
    InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Announces FDA Receipt of ANDA for KETAFREE With July 2026 Review Goal Date
    Via Investor Brand Network
    NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Schedules Corporate Update Call for Dec. 2
    Via Investor Brand Network
    News headline image
    NRx Pharmaceuticals Announces US Food and Drug Administration (FDA) Receipt of ANDA for KETAFREE™, a Preservative-Free IV Ketamine
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    NRx Pharmaceuticals (NASDAQ: NRXP) and HOPE Therapeutics to Host Corporate Update Call
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Present at NobleCon21
    Via Investor Brand Network
    News headline image
    NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to Present at NobleCon21 - Noble Capital Markets’ Twenty First Annual Emerging Growth Equity Conference
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    New to The Street Show #702 Airs Today on Bloomberg at 6:30 PM EST
    Via ACCESS Newswire
    News headline image
    Three Revenue-Generating Facilities in Florida Plus Six More by Year-End in Expanding $750 Million Market Suicidal Depression Market: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
    Via Get News
    BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Reports Q3 Results and Advances NRX-100 and NRX-101 Regulatory Programs
    Via Investor Brand Network

    Frequently Asked Questions

    Is NRX Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, NRX Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does NRX Pharmaceuticals, Inc. - Common Stock trade on?
    NRX Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for NRX Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for NRX Pharmaceuticals, Inc. - Common Stock is NRXP on the Nasdaq Stock Market
    What is the current price of NRX Pharmaceuticals, Inc. - Common Stock?
    The current price of NRX Pharmaceuticals, Inc. - Common Stock is 1.855
    When was NRX Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of NRX Pharmaceuticals, Inc. - Common Stock was at 02/23/26 02:01 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.